Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer

R. Mazzucchelli, F. Barbisan, A. Santinelli, A. Lopez-Beltran, L. Cheng, M. Scarpelli, Rodolfo Montironi

Research output: Contribution to journalArticle

16 Scopus citations


High expression of Prostate Stem Cell Antigen (PSCA) has been shown to be associated with adverse prognostic features in clinically-diagnosed prostate cancer. The aim of this study is to analyze PSCA expression in cystoprostatectomies with incidental prostate carcinoma (PCa). PSCA expression was evaluated immunohistochemically in normal-looking epithelium (NEp), high-grade prostatic intraepithelial neoplasia (HGPIN) and pT2a Gleason score 6 acinar adenocarcinoma. The evaluation was carried out on 20 cystoprostatectomies (CyPs) with incidental PCa from men with bladder urothelial carcinoma (UC), and 20 radical prostatectomies (RPs) with hormonally untreated PCa from men with clinically detected PCa. Ki-67 was also investigated. The percentages of PSCA positive cells in HGPIN were significantly higher than in NEp (NEp: CyP, mean 2.92% ± standard deviation 6.26%; RP, 3.5% ± 6.46%. HGPIN: CyP, 13.67% ± 12.78%; RP, 14.67% ± 11.34%) (p<0.001). The proportions of positive cells in PCa were greater than in HGPIN (CyP, 20.25% ± 15.96%; RP, 22.58% ± 13.67%) (p<0.001). For Ki-67 labeling, the proportions of positive nuclei in the CyPs significantly increased from NEp through HGPIN to PCa. A similar trend was seen in the RPs. In the CyPs the percentages of PSCA and Ki67 positive cells were lower than in the RPs, the differences between the CyP and RP compartments being not statistically significant. Our findings suggest that PSCA is a marker associated with neoplastic transformation of prostate cells, both in CyPs and RPs. However, there are no significant differences between CyPs with incidental prostate carcinoma and RPs with clinically diagnosed cancer.

Original languageEnglish (US)
Pages (from-to)755-762
Number of pages8
JournalInternational Journal of Immunopathology and Pharmacology
Issue number3
StatePublished - Jan 1 2009


  • Cystoprostatectomy incidental cancer
  • High-grade prostatic intraepithelial neoplasia
  • Insignificant cancer
  • Prostate cancer
  • Prostate stem cell antigen
  • Prostatic carcinogenesis
  • Significant cancer

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Immunohistochemical expression of prostate stem cell antigen in cystoprostatectomies with incidental prostate cancer'. Together they form a unique fingerprint.

  • Cite this